Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-03

Clinical Trial Update: Trial of Montelukast in Eosinophilic Esophagitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating montelukast for eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Esophagitis | Phase 1 | Status: COMPLETED